ARTICLE | Clinical News
Theelin estrone injectable suspension regulatory update
December 24, 2001 8:00 AM UTC
KG will withdraw its NDA for Theelin to treat moderate to severe vasomotor symptoms of menopause and vaginal and vulvar atrophy. KG said the FDA requested additional clinical trials and bioavailabilit...